Trova sperimentazioni cliniche nella tua zona
Cerca per malattia e posizione per scoprire le sperimentazioni cliniche disponibili che corrispondono ai tuoi criteri.
↓
Sperimentazioni cliniche corrispondenti
Studio su Spartalizumab e combinazione di farmaci per carcinoma a cellule squamose anale metastatico
Arruolamento non iniziato
Malattie in studio:Farmaci in studio:
Studio sull’uso del ferro derisomaltosio per trattare l’anemia da carenza di ferro nei pazienti anziani dopo chirurgia cardiaca
Arruolamento non iniziato
Malattie in studio:Farmaci in studio:
Studio su Metformina e Colchicina per il Trattamento delle Sequele Post-Acute dell’Infezione da SARS-CoV-2 (PASC)
Arruolamento non iniziato
Farmaci in studio:
Studio sull’efficacia del complesso protrombinico umano nei pazienti con emorragia acuta in terapia con anticoagulanti orali diretti e inibitori del fattore Xa
Arruolamento non iniziato
Malattie in studio:Farmaci in studio:
Studio su Azatioprina, Metotrexato e Adalimumab per Pazienti con Malattia di Crohn
Arruolamento non iniziato
Studio sulla Sicurezza e Tollerabilità di SPL84 nei Pazienti con Fibrosi Cistica
Arruolamento non iniziato
Malattie in studio:Farmaci in studio:- 2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOURIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANOYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOURIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-URIDINE SODIUM SALT
- Spl84
- 2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOURIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANOYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOURIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-P-THIOCYTIDYLYL-(3′-O->5′-O)-2′-O-(2-METHOXYETHYL)-5-METHYL-URIDINE SODIUM SALT
+4
